• In May 2026, Hyliion Holdings Corp. announced that the U.S. Navy’s Office of Naval Research, working with DARPA, had selected the unmanned USX-1 Defiant vessel to test an 800 KW shipboard power system built from four 200 KW KARNO Cores under a funded sea trials program.
• This Navy deployment, arriving shortly after Hyliion’s lab proof of seamless multi-fuel operation for its next-generation KARNO reactor, highlights how fuel-flexible, low-maintenance onboard power is being evaluated for long-duration autonomous missions where reliability and minimal servicing are critical.
• Now, we’ll examine how selection of KARNO for USX-1 Defiant influences Hyliion’s investment narrative, especially around defense-driven energy resilience.

This technology could replace computers: discover 27 stocks that are working to make quantum computing a reality.

Hyliion Holdings Investment Narrative Recap

To own Hyliion today, you need to believe KARNO can move from promising prototypes to commercially accepted, fuel-flexible power systems across data centers and defense. The USX-1 Defiant selection reinforces defense interest in modular, unmanned power, but does not remove the near term commercialization risk around UL certification, customer field trials and timely Navy deployment, which still looks like the key catalyst and the biggest execution risk.

The recent uninterrupted multi fuel KARNO reactor demonstration ties directly into the Navy trials, since USX-1 Defiant will rely on that fuel flexibility to support mission resilience and long duration autonomy. Together, these milestones sit at the heart of Hyliion’s thesis that a single, fuel agnostic architecture can address both stationary and defense use cases, potentially accelerating initial 200 kilowatt KARNO Power Module uptake if field results align with expectations.

Yet, while the technology story is improving, investors should also be aware that any further delays in UL certification or Navy deployment could...

Hyliion Holdings' narrative projects $154.7 million revenue and $18.3 million earnings by 2028. This requires 230.8% yearly revenue growth and a $76.7 million earnings increase from -$58.4 million today.

Uncover how Hyliion Holdings' forecasts yield a $5.00 fair value, a 17% downside to its current price.

Exploring Other Perspectives

Four members of the Simply Wall St Community see Hyliion’s fair value between US$3.50 and about US$9.30, underscoring how far opinions can stretch. Against that spread, the central question remains whether KARNO’s Navy and commercial milestones translate into timely, UL certified deployments that support the business before current cash resources run down.

Explore 4 other fair value estimates on Hyliion Holdings - why the stock might be worth 42% less than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Hyliion Holdings research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Hyliion Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Hyliion Holdings' overall financial health at a glance.

Looking For Alternative Opportunities?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• Capitalize on the AI infrastructure supercycle with our selection of the 46 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Outshine the giants: these 14 early-stage AI stocks could fund your retirement.
• AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.